Japanese scientists have identified stem cells that are essential for hair regeneration, aiming to launch a clinical study to apply these cells in a treatment for male pattern baldness.
According to an article published online in the British journal Scientific Reports, Takashi Tsuji, team leader at the government-affiliated Riken research institute, and colleagues established in-vitro culture systems and discovered through an action study that Advanced gas for antibody CD34 and integrin alpha 6 and beta 5, both adhesive proteins, play an important role in continuous hair regeneration along with a glycoprotein called tenascin.
“Loss of hair or teeth is not life-threatening, but it does have a negative impact on quality of life,” Tsuji said. “I hope to start a clinical trial soon. ”
The beginnings of biotechnology Organ Technologies Inc. has led preparatory work for the launch of the study with partners until the work was postponed last autumn due to the recurrence of the pandemic coronavirus infection.
Riken is now seeking donations and looking for partner companies to produce regenerative medicine for those who have lost their hair and teeth.
In the proposed clinical research to cure male pattern baldness, Tsuji’s team plans to extract hair culture from those with the condition using a method he developed in 2007, and then culture the cells back of the heads.
In a time of both misinformation and too much information, quality journalism is more important than ever.
By subscribing, you can help us get the story right.
SUBSCRIBE NOW
PHOTO GALLERY (CLICK TO ENLARGE)
